M. Warner

3.2k total citations
38 papers, 2.5k citations indexed

About

M. Warner is a scholar working on Molecular Medicine, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, M. Warner has authored 38 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Medicine, 16 papers in Infectious Diseases and 12 papers in Clinical Biochemistry. Recurrent topics in M. Warner's work include Antibiotic Resistance in Bacteria (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Bacterial Identification and Susceptibility Testing (12 papers). M. Warner is often cited by papers focused on Antibiotic Resistance in Bacteria (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Bacterial Identification and Susceptibility Testing (12 papers). M. Warner collaborates with scholars based in United Kingdom, France and Maldives. M. Warner's co-authors include David M. Livermore, Shazad Mushtaq, Neil Woodford, Alan P. Johnson, Mary E. Kaufmann, Jane F. Turton, N. Woodford, D. M. Livermore, Michel Doumith and Sunil Maharjan and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

M. Warner

37 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Warner United Kingdom	26	1.8k	834	652	579	578	38	2.5k
Marina Warner United Kingdom	25	2.0k 1.1×	1.1k 1.3×	563 0.9×	577 1.0×	400 0.7×	44	2.5k
Michael J. Dowzicky United States	33	1.9k 1.1×	887 1.1×	609 0.9×	394 0.7×	827 1.4×	80	2.8k
José María Casellas Argentina	17	2.1k 1.2×	669 0.8×	752 1.2×	714 1.2×	384 0.7×	36	2.7k
Irene Galani Greece	32	2.6k 1.4×	1.2k 1.4×	838 1.3×	800 1.4×	421 0.7×	77	3.3k
James W. Biddle United States	23	2.1k 1.2×	622 0.7×	591 0.9×	950 1.6×	535 0.9×	35	3.1k
Simona Bratu United States	24	2.8k 1.6×	1.1k 1.3×	609 0.9×	1.0k 1.7×	472 0.8×	31	3.2k
Demei Zhu China	25	1.3k 0.7×	594 0.7×	633 1.0×	387 0.7×	444 0.8×	65	2.0k
Samuel K. Bouchillon United States	31	1.9k 1.1×	1.1k 1.3×	683 1.0×	425 0.7×	413 0.7×	51	2.6k
Alejandra Corso Argentina	29	1.4k 0.8×	382 0.5×	843 1.3×	669 1.2×	529 0.9×	119	2.5k
Annarita Mazzariol Italy	22	1.4k 0.8×	395 0.5×	529 0.8×	598 1.0×	396 0.7×	67	2.0k

Countries citing papers authored by M. Warner

Since Specialization

Citations

This map shows the geographic impact of M. Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Warner more than expected).

Fields of papers citing papers by M. Warner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Warner. The network helps show where M. Warner may publish in the future.

Co-authorship network of co-authors of M. Warner

This figure shows the co-authorship network connecting the top 25 collaborators of M. Warner. A scholar is included among the top collaborators of M. Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Warner. M. Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Livermore, David M., M. Warner, & Shazad Mushtaq. (2013). Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 68(10). 2286–90. 225 indexed citations

Livermore, David M., et al.. (2012). Characterization of -lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104). Journal of Antimicrobial Chemotherapy. 67(6). 1354–1358. 52 indexed citations

Reynolds, Rosy, Russell Hope, M. Warner, et al.. (2012). Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07. Journal of Antimicrobial Chemotherapy. 67(12). 2912–2918. 22 indexed citations

Giske, Christian G., Lena Gezelius, Ørjan Samuelsen, et al.. (2010). A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clinical Microbiology and Infection. 17(4). 552–556. 179 indexed citations

Mushtaq, Shazad, M. Warner, & David M. Livermore. (2010). In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters. Journal of Antimicrobial Chemotherapy. 65(11). 2376–2381. 111 indexed citations

Mushtaq, Shazad, M. Warner, G. Williams, Ian A. Critchley, & David M. Livermore. (2010). Activity of chequerboard combinations of ceftaroline and NXL104 versus -lactamase-producing Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 65(7). 1428–1432. 71 indexed citations

Mushtaq, Shazad, et al.. (2010). Performance of the Oxoid M.I.C.EvaluatorTM Strips compared with the Etest(R) assay and BSAC agar dilution. Journal of Antimicrobial Chemotherapy. 65(8). 1702–1711. 10 indexed citations

Livermore, D. M., Shazad Mushtaq, & M. Warner. (2009). Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms. Journal of Antimicrobial Chemotherapy. 64(2). 330–335. 21 indexed citations

Mushtaq, Shazad, M. Warner, & David M. Livermore. (2009). Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters. Journal of Antimicrobial Chemotherapy. 65(2). 266–270. 53 indexed citations

10.

Ellington, Matthew J., Claire Perry, M. Ganner, et al.. (2009). Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales. European Journal of Clinical Microbiology & Infectious Diseases. 28(9). 1113–1121. 44 indexed citations

11.

Livermore, David M., Russell Hope, Shazad Mushtaq, & M. Warner. (2008). Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers. Clinical Microbiology and Infection. 14. 189–193. 51 indexed citations

12.

Woodford, Neil, et al.. (2008). In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. Journal of Antimicrobial Chemotherapy. 62(4). 766–768. 41 indexed citations

13.

Livermore, David M., Shazad Mushtaq, M. Warner, Christine Miossec, & Neil Woodford. (2008). NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases. Journal of Antimicrobial Chemotherapy. 62(5). 1053–1056. 95 indexed citations

14.

Hope, Russell, et al.. (2006). Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 59(1). 110–113. 11 indexed citations

15.

Woodford, Neil, Mary E. Kaufmann, Jane F. Turton, et al.. (2004). Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. Journal of Antimicrobial Chemotherapy. 54(4). 735–743. 411 indexed citations

16.

Johnson, Alan P., et al.. (2004). Characterization of Group B Streptococci Recovered from Infants with Invasive Disease in England and Wales. Clinical Infectious Diseases. 38(9). 1203–1208. 74 indexed citations

17.

Livermore, David M., Shazad Mushtaq, Deborah James, et al.. (2003). In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles. International Journal of Antimicrobial Agents. 22(1). 14–27. 26 indexed citations

18.

Johnson, Alan P., C. J. Henwood, Shazad Mushtaq, et al.. (2003). Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents. Journal of Hospital Infection. 54(3). 179–187. 26 indexed citations

19.

Johnson, Ann, Luke Tysall, Neil Woodford, et al.. (2002). Emerging Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Two Austrian Patients in the Same Intensive Care Unit. European Journal of Clinical Microbiology & Infectious Diseases. 21(10). 751–754. 100 indexed citations

20.

Brown, Derek F. J., M. Warner, C. E. D. Taylor, & R. E. Warren. (1988). Prospective addition of -lactamase to blood culture medium. Journal of Medical Microbiology. 26(2). 147–152. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact